(Q33264523)

24 July 2017

title

Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial (English)

1 reference

24 July 2017

main subject

phase I clinical trial

0 references

0 references

1 reference

1 reference

David J Diemert

7

0 references

Mahamadou A. Thera

object named as

Mahamadou A Thera

1

0 references

Ogobara K. Doumbo

2

object named as

Ogobara K Doumbo

1 reference

24 July 2017

15

Christopher V Plowe

1 reference

24 July 2017

5

Issaka Sagara

1 reference

24 July 2017

6

Alassane Dicko

1 reference

24 July 2017

3

Drissa Coulibaly

1 reference

24 July 2017

4

Dapa A Diallo

1 reference

24 July 2017

14

Kirsten E Lyke

1 reference

24 July 2017

10

Evelina Angov

1 reference

24 July 2017

8

D Gray Heppner

1 reference

24 July 2017

V Ann Stewart

9

1 reference

24 July 2017

Lorraine Soisson

11

1 reference

24 July 2017

Amanda Leach

12

1 reference

24 July 2017

Kathryn Tucker

13

1 reference

24 July 2017

Mali FMP1 Working Group

16

1 reference

24 July 2017

publication date

24 November 2006

1 reference

24 July 2017

1 reference

24 July 2017

volume

1

1 reference

24 July 2017

issue

7

1 reference

24 July 2017

page(s)

e34

1 reference

A high-throughput method for quantifying alleles and haplotypes of the malaria vaccine candidate Plasmodium falciparum merozoite surface protein-1 19 kDa

24 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851722

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851722

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851722

The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851722

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851722

The major merozoite surface protein as a malaria vaccine target

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851722

Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851722

Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851722

Sequence heterogeneity of the C-terminal, Cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples of Plasmodium falciparum

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851722

Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851722

Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851722

Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851722

Community permission for medical research in developing countries

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851722

Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851722

Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851722

Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17124530

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Adjuvant activity of QS-21 isomers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17124530

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PCTR.0010034

1 reference

24 July 2017

1 reference

24 July 2017

1 reference